期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical Feature of Japanese Patients with Fulminant Myocarditis—Myocarditis in Japanese Patients
1
作者 Hiroaki Kawano Yasuhiro Nagayoshi +9 位作者 Sunao Kojima Nahoko Kakihara Satoshi Sakuma Masumi Uchino Aiko Komatsu Machiko Asaka Mitsuhiro Shimomura Hiroshige Yamabe hisao ogawa Koichi Node 《International Journal of Clinical Medicine》 2011年第3期260-263,共4页
Fulminant myocarditis is commonly recognized as an acute myocarditis with cardiogenic shock requiring mechanical support systems. Before the development of mechanical assist devices, previous study described that most... Fulminant myocarditis is commonly recognized as an acute myocarditis with cardiogenic shock requiring mechanical support systems. Before the development of mechanical assist devices, previous study described that most of patients with fulminant myocarditis die at acute phase because of rapidly progressive cardiac decompensation. To investigate the feature of myocarditis, we checked consecutive 18 patients (10 men, 8 women, 12yr-80yr) from April in 2001 to September 2008 in University. Of these patients 3 needed intraaortic balloon pumping (IABP) (2 men, 1 woman), 6 did both IABP and percutaneous cardiopulmonary support (PCPS) (2 men, 4 women). Three patients who need both IABP and PCPS died (2 men, 49yr and 65yr, 1 woman, 54yr) because of uncontrolled bacterial infection. No patients whose age was under 40yr (5 men, 4 women) died although a man needed IABP and 3 women did both IABP and PCPS. Sixteen patients were able to resume a normal life although 1 male patient needed permanent pacemaker, 1 female did cardiac resynchronization therapy, and a male and a female had left ventricular systolic dysfunction. In conclusion, the young patients had better prognosis than older even if mechanical assist is needed. Although half of patients needed mechanical assist, the prevention of multi-organ complications including bacterial infection is one of the most important keys in the treatment of fulminant myocarditis. 展开更多
关键词 MYOCARDITIS MECHANICAL SUPPORT IMMUNOSUPPRESSIVE THERAPY IMMUNOMODULATION THERAPY
下载PDF
Combination Lipid Therapy on Lipid Profiles in Patients with Impaired Glucose Tolerance
2
作者 Hiroaki Kawano Yasuhiro Nagayoshi +1 位作者 hisao ogawa Yoshihiro Kinoshita 《International Journal of Clinical Medicine》 2013年第3期152-157,共6页
Objective: This study compared the effects of combination statin and fibrate therapy with either statin or fibrate monotherapy on lipid profiles in patients with impaired glucose tolerance (IGT) and a high risk for ca... Objective: This study compared the effects of combination statin and fibrate therapy with either statin or fibrate monotherapy on lipid profiles in patients with impaired glucose tolerance (IGT) and a high risk for cardiovascular disease. Methods & Patients: Forty-five patients with IGT and dyslipidemia (men 25, women 20, mean age 61.7 ± 2.4 yrs) were assigned randomly to the 3 treatment groups for a 6-month period. Results: After 6 months of treatment, low density lipoprotein levels decreased in every group, especially the statin and statin + fibrate groups. Triglyceride levels also decreased in all three groups, especially the fibrate and statin + fibrate groups. High density lipoprotein cholesterol and fasting blood glucose levels did not change in any group. The levels of remnant like cholesterol particles decreased in the fibrate and statin + fibrate groups. There was no change during the study in the levels of creatine phosphokinase, lactate dehydrogenase, or creatinine. Conclusion: Combination statin and fibrate therapy results in greater improvement in lipid profiles than monotherapy with either drug. No marked adverse effects were observed with combination therapy during the study. 展开更多
关键词 STATINS FIBRATES DYSLIPIDEMIA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部